πŸ‡ΊπŸ‡Έ FDA
Patent

US 7247653

Pharmaceutical composition

granted A61KA61K31/18A61K31/215

Quick answer

US patent 7247653 (Pharmaceutical composition) held by Takeda Pharmaceutical Company Limited expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/18, A61K31/215, A61K31/27, A61K31/41